The performance of Pacific Edge's Cxbladder Triage test was evaluated in a large, blind study on consenting patients. The findings were equivalent to the previously published performance for Cxbladder Triage, Dr Darling said when contacted. The urologists had no vested interest in what test they used for bladder cancer; they just wanted the best outcome for their patients. Pacific Edge's Cxbladder test was designed to rule out patients who had a low risk of having urothelial cancer (bladder cancer). That meant Cxbladder accurately identified those patients having a low probability of having bladder cancer and not requiring a full work-up for bladder cancer, Dr Darling said.

Source: Otago Daily Times November 14, 2016 17:05 UTC